Total Funding
74
67
Total FundingSeries B raised
Growth Score 74 in past quarter
0 pts
Heat Score 67 in past quarter
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
20319
PleoPharma is a pharmaceutical company that focuses on finding treatments for cannabis related health issues.
- Jay Constantine: Director, Co-Founder, and CMO
Robert Finizio: Executive DirectorPast Role: TherapeuticsMD, Chief Executive Officer and Founder
About the Company
PleoPharma develops therapies aimed at addressing unmet medical needs in areas such as central nervous system disorders and substance use. Its work focuses on advancing a lead treatment through clinical studies. The company emphasizes collaboration with healthcare professionals, research institutions, and industry stakeholders to support its
development efforts.
Women Founded